A Study to Evaluate 5 μg/kg Tbo-filgrastim in Infants, Children and Adolescents With Solid Tumors Without Bone Marrow Involvement
Clinical trial NCT02190721 · COMPLETED
Trial details
- NCT number
- NCT02190721
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-12
- Primary completion
- 2017-04-04
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.